{"nct_id":"NCT03727750","title":"Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2019-07-03","start_date_type":"ACTUAL","primary_completion_date":"2021-04-27","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-27","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["PFE"]}